Garraway To Give NCI Seminar, July 24
Dr. Levi Garraway is the featured guest speaker for the next lecture in NCI’s Center to Reduce Cancer Health Disparities’ Continuing Umbrella of Research Experiences (CURE) Distinguished Scholars Seminar on Tuesday, July 24 from 2 to 3:30 p.m. at the NCI Shady Grove Campus in Rm. TE406. The title of his lecture is Molecular and Genomic Characterization of Human Solid Tumors.
Garraway is senior vice president of global oncology and medical affairs at Eli Lilly and Co., associate professor of medicine in the medical oncology service at the Dana-Farber Cancer Institute and Broad Institute. He is also director of the Joint Center for Cancer Precision Medicine and co-leader of the Cancer Genetics Program at Dana-Farber/Harvard Cancer Center.
Garraway has served on national and international committees including former Vice President Biden’s Blue Ribbon Panel to develop recommendations for the Cancer Moonshot Initiative. He currently serves on the American Association for Cancer Research (AACR) board of directors and in 2016 was president of the American Society of Clinical Investigation—one of the highest honors for academic clinician scientists.
The author of nearly 200 peer-reviewed scientific articles, Garraway has received several awards, including the Paul Marks Prize for Cancer Research, the Jane Cooke Wright Award from AACR, NIH’s New Innovator Award and an Outstanding Investigator Award from NCI. His industry activities include founder of Foundation Medicine, a leading company in cancer genomics diagnostics.
Internationally recognized for his work on genomic alterations in cancer for the purpose of identifying therapeutic interventions, Garraway received his M.D. and Ph.D. degrees from Harvard Medical School.
To register for the seminar via WebEx, visit https://bit.ly/2KuF17P. For reasonable accommodation, call (301) 402-1366 or the Federal Relay (1-800-877-8339).